143 related articles for article (PubMed ID: 27067506)
1. Targeted Radionuclide Therapy of Melanoma.
Norain A; Dadachova E
Semin Nucl Med; 2016 May; 46(3):250-9. PubMed ID: 27067506
[TBL] [Abstract][Full Text] [Related]
2. Targeting Melanin in Melanoma with Radionuclide Therapy.
Allen KJH; Malo ME; Jiao R; Dadachova E
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076924
[TBL] [Abstract][Full Text] [Related]
3. Renaissance of targeting molecules for melanoma.
Dadachova E; Casadevall A
Cancer Biother Radiopharm; 2006 Dec; 21(6):545-52. PubMed ID: 17257069
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
[TBL] [Abstract][Full Text] [Related]
5. Phage display library derived peptides that bind to human tumor melanin as potential vehicles for targeted radionuclide therapy of metastatic melanoma.
Howell RC; Revskaya E; Pazo V; Nosanchuk JD; Casadevall A; Dadachova E
Bioconjug Chem; 2007; 18(6):1739-48. PubMed ID: 17907769
[TBL] [Abstract][Full Text] [Related]
6. Melanoma stem cells in experimental melanoma are killed by radioimmunotherapy.
Jandl T; Revskaya E; Jiang Z; Harris M; Dorokhova O; Tsukrov D; Casadevall A; Dadachova E
Nucl Med Biol; 2013 Feb; 40(2):177-81. PubMed ID: 23146306
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of melanin-binding decapeptide 4B4 radiolabeled with 177Lu, 166Ho, and 153Sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma.
Ballard B; Jiang Z; Soll CE; Revskaya E; Cutler CS; Dadachova E; Francesconi LC
Cancer Biother Radiopharm; 2011 Oct; 26(5):547-56. PubMed ID: 21970319
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Insights into Synergy between Melanin-Targeting Radioimmunotherapy and Immunotherapy in Experimental Melanoma.
Malo ME; Allen KJH; Jiao R; Frank C; Rickles D; Dadachova E
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218169
[TBL] [Abstract][Full Text] [Related]
9. Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a mAb to melanin.
Dadachova E; Nosanchuk JD; Shi L; Schweitzer AD; Frenkel A; Nosanchuk JS; Casadevall A
Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14865-70. PubMed ID: 15469923
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease.
Dadachova E; Moadel T; Schweitzer AD; Bryan RA; Zhang T; Mints L; Revskaya E; Huang X; Ortiz G; Nosanchuk JS; Nosanchuk JD; Casadevall A
Cancer Biother Radiopharm; 2006 Apr; 21(2):117-29. PubMed ID: 16706632
[TBL] [Abstract][Full Text] [Related]
11. Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations.
Schweitzer AD; Rakesh V; Revskaya E; Datta A; Casadevall A; Dadachova E
Melanoma Res; 2007 Oct; 17(5):291-303. PubMed ID: 17885584
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of melanoma: efficacy and mode of action.
Wieder T; Brenner E; Braumüller H; Röcken M
J Dtsch Dermatol Ges; 2016 Jan; 14(1):28-37. PubMed ID: 26713633
[TBL] [Abstract][Full Text] [Related]
13. Melanin as a potential target for radionuclide therapy of metastatic melanoma.
Dadachova E; Casadevall A
Future Oncol; 2005 Aug; 1(4):541-9. PubMed ID: 16556030
[TBL] [Abstract][Full Text] [Related]
14. Complement-dependent cytotoxicity of an antibody to melanin in radioimmunotherapy of metastatic melanoma.
Jandl T; Revskaya E; Jiang Z; Bryan RA; Casadevall A; Dadachova E
Immunotherapy; 2013 Apr; 5(4):357-64. PubMed ID: 23557419
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulating antibodies in the treatment of metastatic melanoma: the experience with anti-CTLA-4, anti-CD137, and anti-PD1.
Simeone E; Ascierto PA
J Immunotoxicol; 2012; 9(3):241-7. PubMed ID: 22524673
[TBL] [Abstract][Full Text] [Related]
16. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U
J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756
[TBL] [Abstract][Full Text] [Related]
17. Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy.
Nosanchuk JD; Jeyakumar A; Ray A; Revskaya E; Jiang Z; Bryan RA; Allen KJH; Jiao R; Malo ME; Gómez BL; Morgenstern A; Bruchertseifer F; Rickles D; Thornton GB; Bowen A; Casadevall A; Dadachova E
Sci Rep; 2018 Apr; 8(1):5466. PubMed ID: 29615812
[TBL] [Abstract][Full Text] [Related]
18. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
[TBL] [Abstract][Full Text] [Related]
19. MSH radiopeptides for targeting melanoma metastases.
Eberle AN; Bapst JP; Calame M; Tanner H; Froidevaux S
Adv Exp Med Biol; 2010; 681():133-42. PubMed ID: 21222266
[TBL] [Abstract][Full Text] [Related]
20. New developments in the treatment of metastatic melanoma: immune checkpoint inhibitors and targeted therapies.
Azijli K; Stelloo E; Peters GJ; VAN DEN Eertwegh AJ
Anticancer Res; 2014 Apr; 34(4):1493-505. PubMed ID: 24692676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
